MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest headlines from journals and sites in the Alfuzosin category. Sun, 21 Mar 2010 18:44:37 +0100 http://www.medworm.com/index.php?rid=3367457&cid=c_8_13_f&fid=35648&url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D16372 Updated Date: Mar 15, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) organizations http://www.medworm.com/rss/comments.php?id=3367457 Mon, 15 Mar 2010 05:00:00 +0100 3367457 http://www.medworm.com/index.php?rid=3346307&cid=c_8_156_f&fid=32407&url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1743-6109.2010.01743.x Conclusions. Alfuzosin 10 mg OD administered for 6 months provides a marked and rapid (within 1 week) improvement in LUTS and bother score while improving both ED and EjD. Leungwattanakij S, Watanachote D, Noppakulsatit P, Petchpaibuol T, Choeypunt N, Tongbai T, Wanamkang T, Lojanapiwat B, Permpongkosol S, Tantiwong A, Pripatnanont C, Akarasakul D, Kongwiwatanakul S, and Chotikawanich E. Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) The Journal of Sexual Medicine journals http://www.medworm.com/rss/comments.php?id=3346307 Mon, 08 Mar 2010 00:00:00 +0100 3346307 http://www.medworm.com/index.php?rid=3233036&cid=c_8_13_f&fid=35648&url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D15023 Updated Date: Feb 2, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) organizations http://www.medworm.com/rss/comments.php?id=3233036 Tue, 02 Feb 2010 05:00:00 +0100 3233036 http://www.medworm.com/index.php?rid=3199702&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600010%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199702 Sat, 23 Jan 2010 15:25:40 +0100 3199702 http://www.medworm.com/index.php?rid=3199703&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600011%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199703 Sat, 23 Jan 2010 15:25:40 +0100 3199703 http://www.medworm.com/index.php?rid=3199704&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600012%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199704 Sat, 23 Jan 2010 15:25:40 +0100 3199704 http://www.medworm.com/index.php?rid=3199705&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600013%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199705 Sat, 23 Jan 2010 15:25:40 +0100 3199705 http://www.medworm.com/index.php?rid=3199706&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600014%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199706 Sat, 23 Jan 2010 15:25:40 +0100 3199706 http://www.medworm.com/index.php?rid=3199707&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600015%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199707 Sat, 23 Jan 2010 15:25:40 +0100 3199707 http://www.medworm.com/index.php?rid=3199708&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600016%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199708 Sat, 23 Jan 2010 15:25:40 +0100 3199708 http://www.medworm.com/index.php?rid=3199709&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600017%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199709 Sat, 23 Jan 2010 15:25:40 +0100 3199709 http://www.medworm.com/index.php?rid=3199710&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600018%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199710 Sat, 23 Jan 2010 15:25:40 +0100 3199710 http://www.medworm.com/index.php?rid=3199711&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600019%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199711 Sat, 23 Jan 2010 15:25:40 +0100 3199711 http://www.medworm.com/index.php?rid=3199712&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600020%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199712 Sat, 23 Jan 2010 15:25:40 +0100 3199712 http://www.medworm.com/index.php?rid=3199713&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600021%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199713 Sat, 23 Jan 2010 15:25:40 +0100 3199713 http://www.medworm.com/index.php?rid=3199714&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600022%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199714 Sat, 23 Jan 2010 15:25:40 +0100 3199714 http://www.medworm.com/index.php?rid=3199715&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600023%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199715 Sat, 23 Jan 2010 15:25:40 +0100 3199715 http://www.medworm.com/index.php?rid=3199716&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600024%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199716 Sat, 23 Jan 2010 15:25:40 +0100 3199716 http://www.medworm.com/index.php?rid=3199717&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600025%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199717 Sat, 23 Jan 2010 15:25:40 +0100 3199717 http://www.medworm.com/index.php?rid=3199718&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600026%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199718 Sat, 23 Jan 2010 15:25:40 +0100 3199718 http://www.medworm.com/index.php?rid=3199719&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600027%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199719 Sat, 23 Jan 2010 15:25:40 +0100 3199719 http://www.medworm.com/index.php?rid=3199720&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600028%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199720 Sat, 23 Jan 2010 15:25:40 +0100 3199720 http://www.medworm.com/index.php?rid=3199721&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600029%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199721 Sat, 23 Jan 2010 15:25:40 +0100 3199721 http://www.medworm.com/index.php?rid=3199722&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000600030%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: The therapeutic system was found to be dermatologically non-irritant and hence, a therapeutically effective amount of alfuzosin hydrochloride can be delivered via a transdermal route. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=3199722 Sat, 23 Jan 2010 15:25:40 +0100 3199722 http://www.medworm.com/index.php?rid=3038837&cid=c_8_47_f&fid=33839&url=http%3A%2F%2Fwww.indianjurol.com%2Farticle.asp%3Fissn%3D0970-1591%3Byear%3D2009%3Bvolume%3D25%3Bissue%3D4%3Bspage%3D474%3Bepage%3D478%3Baulast%3DAgrawal Conclusions&#x0026;lt;/b&#x0026;gt; : TWOC was more successful in men treated with either alfuzosin or tamsulosin and the subsequent need for recatheterization was also reduced. Tamsulosin was comparable to alfuzosin in all respects, except a small but significant side effect of retrograde ejaculation. (Source: Indian Journal of Urology) Indian Journal of Urology journals http://www.medworm.com/rss/comments.php?id=3038837 Mon, 30 Nov 2009 15:59:44 +0100 3038837 http://www.medworm.com/index.php?rid=2962226&cid=c_8_49_f&fid=38731&url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1742-1241.2009.02247.x Conclusions: Based on the analysis of MSHQ scores before and after alfuzosin treatment, improvement was significant on ejaculatory function, in addition to improvement on LUTS and quality of life. MSHQ is a useful tool to evaluate the male sexual dysfunction. (Source: International Journal of Clinical Practice)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> International Journal of Clinical Practice journals http://www.medworm.com/rss/comments.php?id=2962226 Wed, 04 Nov 2009 00:00:00 +0100 2962226 http://www.medworm.com/index.php?rid=2878384&cid=c_8_47_f&fid=32583&url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fend.2009.0173%3Fai%3Drw%26mi%3Do0fy%26af%3DR Journal of Endourology , Vol. 0, No. 0. (Source: Journal of Endourology) Journal of Endourology journals http://www.medworm.com/rss/comments.php?id=2878384 Fri, 09 Oct 2009 11:24:21 +0100 2878384 http://www.medworm.com/index.php?rid=2849964&cid=c_8_47_f&fid=33839&url=http%3A%2F%2Fwww.indianjurol.com%2Farticle.asp%3Fissn%3D0970-1591%3Byear%3D2009%3Bvolume%3D25%3Bissue%3D3%3Bspage%3D423%3Bepage%3D423%3Baulast%3DNirmal Nirmal T J, Singh J CIndian Journal of Urology 2009 25(3):423-423 (Source: Indian Journal of Urology) Indian Journal of Urology journals http://www.medworm.com/rss/comments.php?id=2849964 Thu, 01 Oct 2009 17:55:07 +0100 2849964 http://www.medworm.com/index.php?rid=3014474&cid=c_8_47_f&fid=36728&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19925762%26dopt%3DAbstract CONCLUSIONS: Use of alpha-adrenergic blockers for ureteral distal third stones has been shown to be effective for increasing the stone expulsion rate and even the number of stones passed, and for faster symptom relief. (c) 2009 AEU. Published by Elsevier Espa&#xF1;a, S.L. All rights reserved. PMID: 19925762 [PubMed - as supplied by publisher] (Source: Actas Urologicas Espanolas) Actas Urologicas Espanolas journals http://www.medworm.com/rss/comments.php?id=3014474 Thu, 01 Oct 2009 00:00:00 +0100 3014474 http://www.medworm.com/index.php?rid=2829648&cid=c_8_13_f&fid=33846&url=http%3A%2F%2Fwww.ijpsonline.com%2Farticle.asp%3Fissn%3D0250-474X%3Byear%3D2009%3Bvolume%3D71%3Bissue%3D3%3Bspage%3D252%3Bepage%3D258%3Baulast%3DRoni Roni M A, Kibria G, Jalil RIndian Journal of Pharmaceutical Sciences 2009 71(3):252-258The aim of the present study was the determination of formulation factors and the &#x0026;lt;i&#x0026;gt;in vitro &#x0026;lt;/i&#x0026;gt;evaluation of an extended release dosage form of a freely soluble weakly basic drug (alfuzosin hydrochloride). Binary mixer of one hydrophilic polymer (hydroxypropylmethylcellulose) and one directly compressible Eudragit (RS PO) was used in tablets prepared by direct compression. The amounts of both polymers were taken as independent variables for the 3&#x0026;lt;sup&#x0026;gt; 2&#x0026;lt;/sup&#x0026;gt; Factorial design. The percent drug releases at 1, 6, 12 and 20 h were selected as responses. The main effect and interaction terms were quantitatively evaluated using... Indian Journal of Pharmaceutical Sciences journals http://www.medworm.com/rss/comments.php?id=2829648 Fri, 25 Sep 2009 16:24:50 +0100 2829648 http://www.medworm.com/index.php?rid=2805628&cid=c_8_13_f&fid=35648&url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D11232 Updated Date: Sep 17, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) organizations http://www.medworm.com/rss/comments.php?id=2805628 Thu, 17 Sep 2009 05:00:00 +0100 2805628 http://www.medworm.com/index.php?rid=2722607&cid=c_8_47_f&fid=37429&url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1677-55382009000300026%26lng%3Den%26nrm%3Diso%26tlng%3Den Conclusion: We have shown that curcumin acts on localized prostate cancer to induce apoptosis and may therefore be an option as a future therapeutic agent. (Source: International Braz J Urol) International Braz J Urol journals http://www.medworm.com/rss/comments.php?id=2722607 Sat, 22 Aug 2009 11:13:48 +0100 2722607 http://www.medworm.com/index.php?rid=2714934&cid=c_8_47_f&fid=35929&url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw77ru472n1444329%2F Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11884-009-0026-yAuthors Michel Pontari, Department of Urology at the Temple University School of Medicine Philadelphia USA Journal Current Bladder Dysfunction ReportsOnline ISSN 1931-7220Print ISSN 1931-7212 Journal Volume Volume 4 Journal Issue Volume 4, Number 3 / September, 2009 (Source: Current Bladder Dysfunction Reports) Current Bladder Dysfunction Reports journals http://www.medworm.com/rss/comments.php?id=2714934 Mon, 17 Aug 2009 21:18:13 +0100 2714934 http://www.medworm.com/index.php?rid=2704574&cid=c_8_13_f&fid=33942&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2009%2F00000001%2F00001265%2Fart00015 (Source: Reactions) Reactions journals http://www.medworm.com/rss/comments.php?id=2704574 Mon, 17 Aug 2009 10:19:17 +0100 2704574 http://www.medworm.com/index.php?rid=2642201&cid=c_8_6_f&fid=33554&url=http%3A%2F%2Fcontent.karger.com%2Fproduktedb%2Fprodukte.asp%3Fdoi%3D224867 Urol Int 2009;83:44-48 (DOI:10.1159/000224867) (Source: Karger Publishers) Karger Publishers journals http://www.medworm.com/rss/comments.php?id=2642201 Mon, 27 Jul 2009 15:25:03 +0100 2642201 http://www.medworm.com/index.php?rid=2445541&cid=c_8_47_f&fid=35558&url=http%3A%2F%2Fwww.europeanurology.com%2Farticle%2FPIIS030228380900400X%2Fabstract%3Frss%3Dyes Nickel JC, Krieger JN, McNaughton-Collins M, et al; Chronic Prostatitis Collaborative Research NetworkN Engl J Med 2008;359:2663–73Expert's summaryChronic prostatitis–chronic pelvic pain syndrome (CP/CPPS) is an enigmatic syndrome that affects approximately 10% of men worldwide. The US National Institutes of Health (NIH) initiated studies >10 yr ago to systematically develop a Chronic Prostatitis Symptom Index (NIH-CPSI) and began trials with a variety of agents to ameliorate the symptoms of CP/CPPS. Prior studies had identified α-blockers as potentially effective therapy. A large multicenter randomized double-blind placebo-controlled trial was designed to evaluate the efficacy of alfuzosin, an α-adrenergic receptor blocker, in reducing symptoms in men who were newly diagnosed with C...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> European Urology journals http://www.medworm.com/rss/comments.php?id=2445541 Sun, 31 May 2009 02:45:37 +0100 2445541 http://www.medworm.com/index.php?rid=2421594&cid=c_8_47_f&fid=35929&url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn5g1777hv70737t3%2F This article addresses the effects of food on the current treatments for OAB and LUTS and the clinical considerations for their optimal dosing with regard to food. Content Type Journal ArticleDOI 10.1007/s11884-009-0014-2Authors Helene C. MaltzDavid R. StaskinEdward Zoltan, New York Methodist Hospital One Prospect Park West, Suite C Brooklyn NY 11215 USA Journal Current Bladder Dysfunction ReportsOnline ISSN 1931-7220Print ISSN 1931-7212 Journal Volume Volume 4 Journal Issue Volume 4, Number 2 / June, 2009 (Source: Current Bladder Dysfunction Reports) Current Bladder Dysfunction Reports journals http://www.medworm.com/rss/comments.php?id=2421594 Fri, 15 May 2009 06:04:55 +0100 2421594 http://www.medworm.com/index.php?rid=2395588&cid=c_8_47_f&fid=32576&url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1464-410X.2009.08503.x To assess, using the psychometrically validated Male Sexual Health Questionnaire (MSHQ), the prevalence of ejaculatory dysfunction (EjD) and bother due to EjD in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH), and to assess predictors of EjD in this population. In all, 5999 sexually active men with LUTS completed the International Prostate Symptom Score (IPSS) which rates LUTS severity, and the MSHQ long-form, which evaluates seven EjD symptoms and bother due to EjD. Concomitant intake of medical treatments for BPH and previous BPH-related surgery were collected. The impact of treatments on EjD was compared to a control group (i.e. no previous BPH-related surgery and no medical treatment for BPH). The relationship between EjD, bother due to Ej... BJU International journals http://www.medworm.com/rss/comments.php?id=2395588 Thu, 07 May 2009 04:00:00 +0100 2395588 http://www.medworm.com/index.php?rid=2352383&cid=c_8_47_f&fid=38470&url=http%3A%2F%2Fwww.europeanurology-supplement.com%2Farticle%2FPIIS156990560900030X%2Fabstract%3Frss%3Dyes Conclusions: We propose that ARBs and ARIs have distinct clinical effects and, hence, should be considered for distinct groups of LUTS/BPH patients based on specific treatment goals in a given patient.Take Home Message: While both α-blockers and 5α-reductase inhibitors can reduce male lower urinary tract symptoms and prevent disease progression, their effects differ quantitatively and qualitatively, depending on the end point being studied. Combination treatment is primarily useful to prevent disease progression. (Source: European Urology Supplements) European Urology Supplements journals http://www.medworm.com/rss/comments.php?id=2352383 Wed, 01 Apr 2009 04:00:00 +0100 2352383 http://www.medworm.com/index.php?rid=2283513&cid=c_8_70_f&fid=37624&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19296449%26dopt%3DAbstract In this study we test whether functional screening of compounds to adrenergic G protein-coupled receptors (GPCRs) would provide data that correlated significantly with radiolabeled binding data, thereby permitting researchers to replace expensive radioligand-binding experiments with non-radioactive screening. An increase in intracellular calcium levels represents an important second messenger signal for several recombinant GPCRs. In this study, we describe the affinities of three alpha adrenoceptor antagonists (terazosin, tamsulosin and alfuzosin), determined by monitoring the changes in intracellular calcium levels and comparing them with their radioligand-binding affinities. In addition to determining the functional affinities of the three alpha adrenoceptor antagonists, we evaluate thei... Biotechnology Journal journals http://www.medworm.com/rss/comments.php?id=2283513 Wed, 18 Mar 2009 04:00:00 +0100 2283513 http://www.medworm.com/index.php?rid=2193199&cid=c_8_47_f&fid=32605&url=http%3A%2F%2Fwww.urotoday.com%2F42%2Fbrowse_categories%2Ferectile_dysfunction_ed%2Feffects_of_alfuzosin_and_tamsulosin_on_sperm_parameters_in_healthy_men_results_of_a_shortterm_randomized_doubleblind_placebocontrolled_crossover_study__abstract.html Ejaculation disorders are associated with tamsulosin treatment for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH). (Source: UroToday)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> UroToday info http://www.medworm.com/rss/comments.php?id=2193199 Tue, 17 Feb 2009 23:00:00 +0100 2193199 http://www.medworm.com/index.php?rid=2168026&cid=c_8_47_f&fid=36204&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19193417%26dopt%3DAbstract CONCLUSIONS: Medical treatment of lower ureteral calculi with tamsulosin and alfuzosin resulted in a significantly increased stone expulsion rate, decreased expulsion time, and a reduced need for analgesic therapy. PMID: 19193417 [PubMed - as supplied by publisher] (Source: Urology) Urology journals http://www.medworm.com/rss/comments.php?id=2168026 Mon, 02 Feb 2009 05:00:00 +0100 2168026 http://www.medworm.com/index.php?rid=2138152&cid=c_8_47_f&fid=36204&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19167031%26dopt%3DAbstract CONCLUSIONS: These results have provided additional evidence of the link between LUTS/BPH and sexual dysfunction in aging men and support clinical trial results indicating different rates of sexual side effects for BPH medical therapies. PMID: 19167031 [PubMed - as supplied by publisher] (Source: Urology) Urology journals http://www.medworm.com/rss/comments.php?id=2138152 Wed, 21 Jan 2009 05:00:00 +0100 2138152 http://www.medworm.com/index.php?rid=2066578&cid=c_8_58_f&fid=23305&url=http%3A%2F%2Ffeeds.sciencedaily.com%2F%7Er%2Fsciencedaily%2F%7E3%2F95QMYM9LorI%2F081218122200.htm Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases. (Source: ScienceDaily Headlines) ScienceDaily Headlines news http://www.medworm.com/rss/comments.php?id=2066578 Sun, 28 Dec 2008 03:32:48 +0100 2066578 http://www.medworm.com/index.php?rid=2063570&cid=c_8_5_f&fid=28817&url=http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F133724.php A commonly-prescribed drug for men suffering from a painful pelvic condition failed to significantly reduce patients' symptoms in an international study led by Queen's University professor and urologist at Kingston General Hospital, Curtis Nickel. The drug, called Alfuzosin, is regularly prescribed by more than half of family doctors to treat chronic prostititis/chronic pelvic pain syndrome. This affliction is estimated to affect from six to 12 per cent of the population. (Source: Pain / Anesthetics News From Medical News Today) Pain / Anesthetics News From Medical News Today news http://www.medworm.com/rss/comments.php?id=2063570 Wed, 24 Dec 2008 09:00:00 +0100 2063570 http://www.medworm.com/index.php?rid=2058339&cid=c_8_47_f&fid=32590&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F585600%3Fsrc%3Drss Contrary to expectations, the alpha-adrenergic blocker alfuzosin did not alleviate pain in men with chronic prostatitis in a placebo-controlled study conducted by investigators in the Chronic Prostatitis Collaborative Research Network. Reuters Health Information (Source: Medscape Urology Headlines)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> Medscape Urology Headlines info http://www.medworm.com/rss/comments.php?id=2058339 Tue, 23 Dec 2008 15:24:32 +0100 2058339 http://www.medworm.com/index.php?rid=2053656&cid=c_8_34_f&fid=36544&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FDrugscom-ClinicalTrials%2F%7E3%2F489110354%2Fcommon-chronic-prostatitis-fails-reduce-symptoms-6551.html BETHESDA, Md., Dec. 17, 2008--Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been... (Source: Drugs.com - Clinical Trials) Drugs.com - Clinical Trials news http://www.medworm.com/rss/comments.php?id=2053656 Thu, 18 Dec 2008 15:50:46 +0100 2053656 http://www.medworm.com/index.php?rid=2049415&cid=c_8_4_f&fid=27976&url=http%3A%2F%2Fwww.nih.gov%2Fnews%2Fhealth%2Fdec2008%2Fniddk-17.htm Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The study is to be published in the New England Journal of Medicine. (Source: National Institutes of Health (NIH) News Releases) National Institutes of Health (NIH) News Releases news http://www.medworm.com/rss/comments.php?id=2049415 Thu, 18 Dec 2008 13:30:00 +0100 2049415 http://www.medworm.com/index.php?rid=2042995&cid=c_8_26_f&fid=23294&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F585468%3Fsrc%3Drss A study does not support the use of alfuzosin for relieving the symptoms of chronic prostatitis-chronic pelvic pain syndrome in men who have not been treated with an alpha-blocker. Medscape Medical News (Source: Medscape Medical News Headlines) Medscape Medical News Headlines news http://www.medworm.com/rss/comments.php?id=2042995 Wed, 17 Dec 2008 22:00:00 +0100 2042995 http://www.medworm.com/index.php?rid=2043333&cid=c_8_47_f&fid=38005&url=http%3A%2F%2Fwww.medpagetoday.com%2FUrology%2FUrology%2F12206 KINGSTON, Ontario (MedPage Today) -- For chronic prostatitis-chronic pelvic pain syndrome, the alpha-blocker alfuzosin (Uroxatral) did no better than placebo, according to a randomized trial. (Source: MedPage Today Urology) MedPage Today Urology news http://www.medworm.com/rss/comments.php?id=2043333 Wed, 17 Dec 2008 21:00:00 +0100 2043333 http://www.medworm.com/index.php?rid=2044445&cid=c_8_49_f&fid=28854&url=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fshort%2F359%2F25%2F2663%3Frss%3D1%26query%3Dcurrent In this multicenter, randomized, double-blind, placebo-controlled trial, treatment with the alpha-adrenergic receptor blocker alfuzosin (as compared with placebo) did not reduce symptoms in men who had received a diagnosis of chronic prostatitis-chronic pelvic pain syndrome in the preceding 2 years and who had not previously been treated with an alpha-adrenergic receptor blocker. The findings do not support the use of alfuzosin for men in whom chronic prostatitis-chronic pelvic pain syndrome has recently been diagnosed. (Source: New England Journal of Medicine)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> New England Journal of Medicine journals http://www.medworm.com/rss/comments.php?id=2044445 Wed, 17 Dec 2008 05:00:00 +0100 2044445 http://www.medworm.com/index.php?rid=2031209&cid=c_8_47_f&fid=32591&url=http%3A%2F%2Fdx.doi.org%2F10.1038%2Fijir.2008.62 Authors: B-H Chung, J-Y Lee, C-I Kim, C-S Kim, C-Y Oh, S-W Lee, J-S Lee & S-J Yoo (Source: International Journal of Impotence Research) International Journal of Impotence Research journals http://www.medworm.com/rss/comments.php?id=2031209 Thu, 11 Dec 2008 05:00:00 +0100 2031209 http://www.medworm.com/index.php?rid=2021825&cid=c_8_47_f&fid=36077&url=http%3A%2F%2Fwww.jurology.com%2Farticle%2FPIIS0022534708024464%2Fabstract%3Frss%3Dyes Purpose: We assessed the impact of alfuzosin on ureteral stent discomfort.Materials and Methods: A total of 66 patients scheduled for unilateral retrograde ureteroscopy with stent placement provided consent for the study. Patients were randomized between placebo and the study medication, and investigators and patients were blinded to the randomization scheme. To evaluate pain and urinary symptoms patients were asked to complete the Ureteral Stent Symptom Questionnaire (Stone Management Unit, Southmead Hospital, Westbury-on-Trym, United Kingdom) before ureteroscopy and 3 days after the procedure to minimize the confounding impact of procedural discomfort due to surgery. Patients were also asked to maintain a use log of pain medication each day that the ureteral stent was in place. Procedure... The Journal of Urology journals http://www.medworm.com/rss/comments.php?id=2021825 Tue, 09 Dec 2008 11:11:22 +0100 2021825 http://www.medworm.com/index.php?rid=2015167&cid=c_8_156_f&fid=32407&url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1743-6109.2008.01109.x Conclusions. Combined therapy improved ED and LUTS as demonstrated by the significant improvement in uroflowmetry measures and in IPSS and IIEF-EF scores. A significant improvement was also observed in quality of life assessments. The beneficial effects of tadalafil on LUTS similar to the benefits of alfuzosin on ED, although present, were smaller. Liguori G, Trombetta C, Giorgi GD, Pomara G, Maio G, Vecchio D, Ocello G, Ollandini G, Bucci S, and Belgrano E. Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: An integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) The Journal of Sexual Medicine journals http://www.medworm.com/rss/comments.php?id=2015167 Thu, 04 Dec 2008 05:00:00 +0100 2015167 http://www.medworm.com/index.php?rid=1938070&cid=c_8_29_f&fid=33390&url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F16j4l6167j014621%2F Abstract&nbsp;&nbsp;Our objective was to assess the effect of the selective α1-blocker alfuzosin on urodynamic parameters and quality of life in female patients with primary bladder neck obstruction (PBNO). Twenty-five women identified as having PBNO were included in the study. After the initial assessment of urodynamic parameters and bother score index, all patients were treated with alfuzosin 5&nbsp;mg twice daily for 8&nbsp;weeks. After this period of time, the patients were reassessed with the same methodology as pretreatment. Symptoms subjectively improved, and patients’ satisfaction significantly increased in 64% of the patients (16 out of 25). Most urodynamic parameters were also significantly improved after treatment with alfuzosin. Alfuzosin significantly improved urodynam... International Urogynecology Journal journals http://www.medworm.com/rss/comments.php?id=1938070 Tue, 04 Nov 2008 07:12:29 +0100 1938070 http://www.medworm.com/index.php?rid=1885564&cid=c_8_47_f&fid=32576&url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1464-410X.2008.07914.x This study suggests a rationale for further clinical trials using combinations of [alpha]-adrenoceptor antagonists and phosphodiesterase-5 inhibitors in patients with ED and lower urinary tract symptoms. (Source: BJU International)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> BJU International journals http://www.medworm.com/rss/comments.php?id=1885564 Fri, 17 Oct 2008 04:00:00 +0100 1885564 http://www.medworm.com/index.php?rid=1808035&cid=c_8_13_f&fid=32559&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F579524%3Fsrc%3Drss Alpha blockers for stone expulsions--Can they help reduce the severe pain? Ranked "must read" from F1000. Faculty of 1000 Medicine (Source: Medscape Pharmacist Headlines) Medscape Pharmacist Headlines info http://www.medworm.com/rss/comments.php?id=1808035 Fri, 19 Sep 2008 21:59:57 +0100 1808035 http://www.medworm.com/index.php?rid=1582445&cid=c_8_26_f&fid=23292&url=http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F114048.php ORLANDO, FL (UroToday.com) - (Reported from the Annual Meeting of the American Urological Association) There were several randomized clinic trials that suggested a lack of benefit to alpha blocker therapy for Ureteral calculi. Abstract 1491 evaluated tamsulosin vs placebo and Abstract 1410 compared alfuzosin to placbo in untreated patients trying to pass a Ureteral stone. (Source: Health News from Medical News Today) Health News from Medical News Today news http://www.medworm.com/rss/comments.php?id=1582445 Sun, 06 Jul 2008 07:00:00 +0100 1582445 http://www.medworm.com/index.php?rid=1798002&cid=c_8_47_f&fid=36728&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18788486%26dopt%3DAbstract Authors: Mart&#xED;n-Morales A, Meyer G, Ram&#xED;rez E INTRODUCTION: Benign prostatic hyperplasia (BPH) is characterized by lower urinary tract symptoms (LUTS) that may cause ejaculatory disorders, although they could be also a consequence of alpha-blocker treatment. OBJECTIVES: To determine the prevalence of ejaculatory dysfunction in patients with HBP undergoing alpha-blocker therapy. Secondary objectives were to evaluate the effect of different drugs on normal ejaculation and the relationship of dysfunction degree to prognostic factors and BPH severity. MATERIALS AND METHODS: Epidemiologic, transversal, uncontrolled and open-label study in 1.177 patients older than 40, who had been diagnosed of BPH/LUTS with more than 6 months of evolution and treated with the same alpha-blocker fo... Actas Urologicas Espanolas journals http://www.medworm.com/rss/comments.php?id=1798002 Tue, 01 Jul 2008 04:00:00 +0100 1798002 http://www.medworm.com/index.php?rid=1533836&cid=c_8_47_f&fid=32586&url=http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F112055.php ORLANDO, FL (UroToday.com) - Medical expulsive therapy for ureteral calculi has been established in several randomized controlled clinical trials. However, the exact mechanism of action and the extent of their influence on renal pelvic and ureteral dynamics has not been elucidated. In a novel model, Das and colleagues from Saint Louis, Missouri studied the effects of an oral alpha blocker (alfuzosin HCL) on ureteral peristalsis, intrapelvic pressure (IPP) and stone movement. (Source: Urology / Nephrology News From Medical News Today) Urology / Nephrology News From Medical News Today news http://www.medworm.com/rss/comments.php?id=1533836 Fri, 20 Jun 2008 08:00:00 +0100 1533836 http://www.medworm.com/index.php?rid=1529487&cid=c_8_47_f&fid=32586&url=http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F111873.php ORLANDO, FL (UroToday.com) - Medical expulsive therapy for the management of distal ureteral calculi has been shown in several randomized controlled trials to decrease the time to stone expulsion and to increase the stone passage rate. In a new study with the alpha blocker alfuzosin, Pedro and colleagues from Minnesota performed a randomized controlled double blind study to evaluate the efficacy of alfuzosin for medical expulsive therapy for distal ureteral stone passage. (Source: Urology / Nephrology News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> Urology / Nephrology News From Medical News Today news http://www.medworm.com/rss/comments.php?id=1529487 Thu, 19 Jun 2008 08:00:00 +0100 1529487 http://www.medworm.com/index.php?rid=1521015&cid=c_8_47_f&fid=32586&url=http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F111310.php ORLANDO, FL (UroToday.com) - In this Level I prospective randomized study, either alfuzosin (10 mg) or tolterodine (4mg) per day, resulted in a statistically significant equal decrease in ureteral stent symptoms. However, the overall decrease for either drug was only 21%.Of interest, but understandable, the pain index decreased more with alfuzosin ( a 50% drop) while the symptoms of bladder irritation decreased more with tolterodine (but only by 8-21%). (Source: Urology / Nephrology News From Medical News Today) Urology / Nephrology News From Medical News Today news http://www.medworm.com/rss/comments.php?id=1521015 Sun, 15 Jun 2008 11:00:00 +0100 1521015 http://www.medworm.com/index.php?rid=1511189&cid=c_8_47_f&fid=32586&url=http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F110918.php ORLANDO, FL (UroToday.com) - Results from the NIH Randomized Multicenter Double-Blind Placebo Controlled Trial. Dr. Nickel presented the use of alfuzosin in the treatment of chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS). CP is extremely prevalent with 6-9% of men suffering from this. Treatment of CP is more costly in North America than treatment for type II diabetes mellitus, he said. (Source: Urology / Nephrology News From Medical News Today) Urology / Nephrology News From Medical News Today news http://www.medworm.com/rss/comments.php?id=1511189 Thu, 12 Jun 2008 08:00:00 +0100 1511189 http://www.medworm.com/index.php?rid=1382588&cid=c_8_13_f&fid=35648&url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D7074 Updated Date: Apr 18, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) organizations http://www.medworm.com/rss/comments.php?id=1382588 Fri, 18 Apr 2008 05:00:00 +0100 1382588 http://www.medworm.com/index.php?rid=1280427&cid=c_8_47_f&fid=32576&url=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Fabs%2F10.1111%2Fj.1464-410X.2008.07458.x%3Fai%3Ds8%26mi%3D4mpuw%26af%3DR BJU International, Volume 101, Issue 7, Page 847-852, April 2008. Study Type – Therapy (individual cohort study)Level of Evidence  2b OBJECTIVES To assess the 3-year efficacy and safety of the selective α1-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign ... (Source: BJU International) BJU International journals http://www.medworm.com/rss/comments.php?id=1280427 Wed, 05 Mar 2008 15:22:33 +0100 1280427 http://www.medworm.com/index.php?rid=1167976&cid=c_8_156_f&fid=32407&url=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Fabs%2F10.1111%2Fj.1743-6109.2007.00754.x%3Fai%3Dcf7%26mi%3D4mpuw%26af%3DR The Journal of Sexual Medicine, Volume 0, Issue 0, Page ???, OnlineEarly Articles. ABSTRACT Introduction. Phosphodiesterase type 5 (PDE5) inhibitors, such as tadalafil, are a first-line treatment for erectile dysfunction (ED). Nevertheless, some patients do not respond to this treatment. Clinical data suggest that the addition of α1-... (Source: The Journal of Sexual Medicine)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> The Journal of Sexual Medicine journals http://www.medworm.com/rss/comments.php?id=1167976 Tue, 22 Jan 2008 15:29:25 +0100 1167976 http://www.medworm.com/index.php?rid=1103162&cid=c_8_47_f&fid=33391&url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm41300k168227158%2F Conclusion&nbsp;&nbsp;Different alpha-blockers, which are used during different time frames in the same individuals, provide similar efficiency outcome. When the desired effect in the treatment for BPH could not be obtained with one alpha-blocker, there may not be any benefit in switching to another one. Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s11255-007-9312-9Authors Temucin Senkul, Gulhane Military Medical Faculty Istanbul, Uskudar 34668 TurkeyOmer Yilmaz, Gulhane Military Medical Faculty Istanbul, Uskudar 34668 TurkeyCuneyt Iseri, Gulhane Military Medical Faculty Istanbul, Uskudar 34668 TurkeyCuneyt Adayener, Gulhane Military Medical Faculty Istanbul, Uskudar 34668 TurkeyIlker Akyol, Gulhane Military Medical Faculty Istanbul, Uskudar 34668 TurkeyFerha... International Urology and Nephrology journals http://www.medworm.com/rss/comments.php?id=1103162 Sun, 16 Dec 2007 18:51:46 +0100 1103162 http://www.medworm.com/index.php?rid=1085903&cid=c_8_13_f&fid=35648&url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D5900 Updated Date: Dec 10, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) organizations http://www.medworm.com/rss/comments.php?id=1085903 Mon, 10 Dec 2007 05:00:00 +0100 1085903 http://www.medworm.com/index.php?rid=916900&cid=c_8_47_f&fid=32590&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F563156%3Fsrc%3Drss This randomized, double-blind, placebo-controlled study describes the effects of 10 mg of alfuzosin daily on erectile and ejaculatory function in men with symptomatic BPH. International Journal of Impotence Research (Source: Medscape Urology Headlines) Medscape Urology Headlines info http://www.medworm.com/rss/comments.php?id=916900 Mon, 01 Oct 2007 20:42:59 +0100 916900 http://www.medworm.com/index.php?rid=912143&cid=c_8_13_f&fid=35648&url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D5379 Updated Date: Sep 28, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) organizations http://www.medworm.com/rss/comments.php?id=912143 Fri, 28 Sep 2007 05:00:00 +0100 912143 http://www.medworm.com/index.php?rid=905078&cid=c_8_26_f&fid=23298&url=http%3A%2F%2Fwww.news-medical.net%2F%3Fid%3D30341 Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg. (Source: News-Medical News Feed)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> News-Medical News Feed news http://www.medworm.com/rss/comments.php?id=905078 Wed, 26 Sep 2007 20:01:00 +0100 905078 http://www.medworm.com/index.php?rid=903620&cid=c_8_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2020723 WOODCLIFF LAKE, N.J., Sept. 25 (HSMN NewsFeed) -- Barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its URO... Biopharmaceuticals, Generics, LitigationBarr Pharmaceuticals, UROXATRAL, alfuzosin, sanofi-aventis (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=903620 Tue, 25 Sep 2007 21:07:53 +0100 903620 http://www.medworm.com/index.php?rid=838393&cid=c_8_47_f&fid=32605&url=http%3A%2F%2Fwww.urotoday.com%2Fbrowse_categories%2Fbladder_cancer_diagnosis_and_monitoring_center%2Feffects_of_alfuzosin_10_mg_once_daily_on_sexual_function_in_men_treated_for_symptomatic_benign_prostatic_hyperplasia__abstract.html New England Research Institutes, Watertown, MA, USA. (Source: UroToday) UroToday info http://www.medworm.com/rss/comments.php?id=838393 Mon, 03 Sep 2007 23:00:00 +0100 838393 http://www.medworm.com/index.php?rid=909773&cid=c_8_17_f&fid=30410&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17898558%26dopt%3DAbstract We describe a 56-year-old man who developed an acute liver injury after taking alfuzosin for 1 month to control his newly diagnosed benign prostatic hypertrophy (BPH). There was no history of alcohol consumption or the taking herbal or traditional remedies. Viral causes, autoimmune hepatitis, and biliary tree obstruction were excluded. Other rare causes of hepatitis such as hemochromatosis, primary biliary cirrhosis and Wilson's disease were also absent in this patient. His liver test results began to improve after discontinuing the alfuzosin. Two weeks later, alfuzosin was administered again because the patient complained of dysuria. After 10 days of alfuzosin reuse, his liver test results worsened. Five months later after the complete discontinuation of the drug, his liver test results h... Korean J Hepatol journals http://www.medworm.com/rss/comments.php?id=909773 Sat, 01 Sep 2007 04:00:00 +0100 909773 http://www.medworm.com/index.php?rid=832659&cid=c_8_13_f&fid=35648&url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D5060 Updated Date: Aug 30, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) organizations http://www.medworm.com/rss/comments.php?id=832659 Thu, 30 Aug 2007 05:00:00 +0100 832659 http://www.medworm.com/index.php?rid=818197&cid=c_8_47_f&fid=32591&url=http%3A%2F%2Fdx.doi.org%2F10.1038%2Fsj.ijir.3901554 Effects of alfuzosin 10&#8201;mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia International Journal of Impotence Research advance online publication, August 23, 2007. doi:10.1038/sj.ijir.3901554 Authors: R Rosen, A Seftel & C G Roehrborn (Source: International Journal of Impotence Research)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> International Journal of Impotence Research journals http://www.medworm.com/rss/comments.php?id=818197 Thu, 23 Aug 2007 04:00:00 +0100 818197 http://www.medworm.com/index.php?rid=1481743&cid=c_8_59_f&fid=37005&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17979639%26dopt%3DAbstract Authors: Gupta VK, Singh AK, Gupta B The construction and characterization of potentiometric membrane electrodes are described for the quantification of alfuzosin, a drug used in a mono- and combined therapy of benign prostatic hyperplasia (BPH). The membranes of these electrodes consist of alfuzosin hydrochloride-tetraphenyl borate, (Az-TPB), chlorophenyl borate (Az-ClPB), and phosphotungstate (Az(3)-PT) ion associations as molecular recognition reagent dispersed in PVC matrix with dioctylpthalate as plasticizer. The performance characteristics of these electrodes, which were evaluated according to IUPAC recommendations, revealed a fast, stable and liner response for alfuzosin over the concentration ranges of 8.3 x 10(-6) to 1.0 x 10(-2) M, 3.8 x 10(-6) to 1.0 x 10(-2) M, 7.5 x 10(-7)... Combinatorial Chemistry and High Throughput Screening journals http://www.medworm.com/rss/comments.php?id=1481743 Wed, 01 Aug 2007 04:00:00 +0100 1481743 http://www.medworm.com/index.php?rid=747442&cid=c_8_35_f&fid=28832&url=http%3A%2F%2Fwww.clinicalanswers.nhs.uk%2Findex.cfm%3Fquestion%3D5636 In answering this question, we have restricted the search to medical treatments for chronic urinary retention and thus have excluded surgical interventions. CKS (formerly PRODIGY) have produced a guideline on prostate benign hyperplasia in which treatment options are discussed. (Source: NLH Question Answering Service) NLH Question Answering Service organizations http://www.medworm.com/rss/comments.php?id=747442 Fri, 20 Jul 2007 12:28:20 +0100 747442 http://www.medworm.com/index.php?rid=477145&cid=c_8_13_f&fid=33317&url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy583022308112525%2F Abstract??Our aim was to investigate the effects of two ?1-adrenergic blockers?tamsulosin and alfuzosin?on pupil diameter (PD). In this prospective randomized single-blind clinical trial, 64 patients with benign prostatic hyperplasia received treatment with either tamsulosin or alfuzosin. The same ophthalmologist, masked to the given medication, evaluated patients prior to, 4 weeks after and 6 months after the start of the medication (day 0, day 28 and month 6). Best corrected visual acuity and PD under mesopic, scotopic, and dilated conditions were measured.t-test, ANOVA, and Dunnett?s multiple comparison post-test were used for statistical analysis. With tamsulosin treatment, both mesopic and scotopic PD decreased, respectively, from 3.9???0.7?and 5.7???0.6?mm at day 0 to 3.6???0.9 and 5... Naunyn-Schmiedeberg's Archives of Pharmacology journals http://www.medworm.com/rss/comments.php?id=477145 Fri, 16 Mar 2007 07:49:33 +0100 477145 http://www.medworm.com/index.php?rid=683471&cid=c_8_13_f&fid=35408&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17577460%26dopt%3DAbstract CONCLUSIONS:: The available data suggest that combination alpha(1)ARA/5ARI therapy is beneficial in the treatment of BPH and the associated symptoms. The greatest efficacy was evident in patients with an enlarged prostate, more severe symptoms, and higher PSA levels. There are limited data suggesting that the presence of prostatic inflammation may indicate a greater likelihood of treatment efficacy with combination therapy. PMID: 17577460 [PubMed - in process] (Source: Clinical Therapeutics) Clinical Therapeutics journals http://www.medworm.com/rss/comments.php?id=683471 Thu, 01 Mar 2007 05:00:00 +0100 683471 http://www.medworm.com/index.php?rid=388145&cid=c_8_13_f&fid=33942&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2007%2F00000001%2F00001136%2Fart00012 (Source: Reactions)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> Reactions journals http://www.medworm.com/rss/comments.php?id=388145 Wed, 31 Jan 2007 10:25:03 +0100 388145 http://www.medworm.com/index.php?rid=382816&cid=c_8_13_f&fid=34372&url=http%3A%2F%2Freactions.adisonline.com%2Fpt%2Fre%2Frea%2Fabstract.00128415-200711360-00013.htm (Source: Reactions Weekly) Reactions Weekly journals http://www.medworm.com/rss/comments.php?id=382816 Sat, 27 Jan 2007 05:39:02 +0100 382816 http://www.medworm.com/index.php?rid=348546&cid=c_8_47_f&fid=32593&url=http%3A%2F%2Fdx.doi.org%2F10.1038%2Fsj.pcan.4500925 (Source: Prostate Cancer and Prostatic Diseases) Prostate Cancer and Prostatic Diseases journals http://www.medworm.com/rss/comments.php?id=348546 Tue, 09 Jan 2007 07:00:00 +0100 348546 http://www.medworm.com/index.php?rid=532178&cid=c_8_13_f&fid=35408&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17379044%26dopt%3DAbstract CONCLUSIONS:: The use of 5ARI therapy is a rational approach to symptom management and prevention of long-term negative outcomes in men with enlarged prostates.V 3. PMID: 17379044 [PubMed - in process] (Source: Clinical Therapeutics) Clinical Therapeutics journals http://www.medworm.com/rss/comments.php?id=532178 Mon, 01 Jan 2007 05:00:00 +0100 532178 http://www.medworm.com/index.php?rid=323878&cid=c_8_47_f&fid=32605&url=http%3A%2F%2Fwww.urotoday.com%2F41%2Fbrowse_categories%2Fbph__male_luts%2Feuropean_urology__alfuzosin_10mg_does_not_affect_blood_pressure_in_young_healthy_men.html Volume 50, Issue 6, Pages 1292-1298 (December 2006) Abstract - Objectives: Alfuzosin 10mg is a uroselective &alpha;1-adrenoceptor antagonist used to... (Source: UroToday) UroToday info http://www.medworm.com/rss/comments.php?id=323878 Sun, 17 Dec 2006 23:00:00 +0100 323878 http://www.medworm.com/index.php?rid=289692&cid=c_8_13_f&fid=33942&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2006%2F00000001%2F00001129%2Fart00007 (Source: Reactions)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> Reactions journals http://www.medworm.com/rss/comments.php?id=289692 Sun, 26 Nov 2006 14:23:03 +0100 289692 http://www.medworm.com/index.php?rid=124365&cid=c_8_47_f&fid=32576&url=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Fabs%2F10.1111%2Fj.1464-410X.2006.06426.x%3Fai%3Ds8%26mi%3D4mpuw%26af%3DR BJU International Volume 0, Issue 0, Page ???-???. (Source: BJU International) BJU International journals http://www.medworm.com/rss/comments.php?id=124365 Fri, 28 Jul 2006 09:56:24 +0100 124365 http://www.medworm.com/index.php?rid=106712&cid=c_8_12_f&fid=31719&url=http%3A%2F%2Farchderm.ama-assn.org%2Fcgi%2Fcontent%2Fshort%2F142%2F7%2F938%3Frss%3D1 (Source: Archives of Dermatology) Archives of Dermatology journals http://www.medworm.com/rss/comments.php?id=106712 Mon, 17 Jul 2006 06:00:00 +0100 106712 http://www.medworm.com/index.php?rid=101758&cid=c_8_39_f&fid=32101&url=http%3A%2F%2Fwww.translational-medicine.com%2Fcontent%2F4%2F1%2F31 Conclusion: In our opinion the treatment with tamsulosin may induce retrograde ejaculation but not other ejaculatory disorder due to abnormal sperm progression. (Source: Journal of Translational Medicine) Journal of Translational Medicine journals http://www.medworm.com/rss/comments.php?id=101758 Fri, 14 Jul 2006 06:00:00 +0100 101758 http://www.medworm.com/index.php?rid=105023&cid=c_8_39_f&fid=32101&url=http%3A%2F%2Fwww.translational-medicine.com%2Fcontent%2F4%2F1%2F31 Conclusion: In our opinion the treatment with tamsulosin may induce retrograde ejaculation but not other ejaculatory disorder due to abnormal sperm progression. (Source: Journal of Translational Medicine) Journal of Translational Medicine journals http://www.medworm.com/rss/comments.php?id=105023 Fri, 14 Jul 2006 06:00:00 +0100 105023 http://www.medworm.com/index.php?rid=160159&cid=c_8_39_f&fid=32101&url=http%3A%2F%2Fwww.translational-medicine.com%2Fcontent%2F4%2F1%2F31 Conclusion: In our opinion the treatment with tamsulosin may induce retrograde ejaculation but not other ejaculatory disorder due to abnormal sperm progression. (Source: Journal of Translational Medicine)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> Journal of Translational Medicine journals http://www.medworm.com/rss/comments.php?id=160159 Fri, 14 Jul 2006 06:00:00 +0100 160159 http://www.medworm.com/index.php?rid=12540&cid=c_8_156_f&fid=32599&url=http%3A%2F%2Fwww.urologytimes.com%2Furologytimes%2Farticle%2FarticleDetail.jsp%3Fid%3D122047%26ref%3D25 San Francisco--Interim results from two multi-national European studies show that once-daily treatment with a uroselective alpha-blocker reduces lower urinary tract symptoms and may benefit sexual function. The drug, alfuzosin (Uroxatral), appears to be efficacious in men with co-morbidities such as hypertension, heart disease, and diabetes, and does not seem to significantly interact with medications for those conditions, according to two separate studies presented at the AUA annual meeting here. (Source: UrologyTimes - Sexual Dysfunction) UrologyTimes - Sexual Dysfunction journals http://www.medworm.com/rss/comments.php?id=12540 Sat, 20 May 2006 06:00:00 +0100 12540 http://www.medworm.com/index.php?rid=23161&cid=c_8_47_f&fid=32576&url=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Fabs%2F10.1111%2Fj.1464-410X.2006.06171.x%3Fai%3Ds8%26mi%3D4mpuw%26af%3DR BJU International Volume 97, Issue 6, Page 1242-1246, Jun 2006 (Source: BJU International) BJU International journals http://www.medworm.com/rss/comments.php?id=23161 Tue, 09 May 2006 13:10:33 +0100 23161 http://www.medworm.com/index.php?rid=12561&cid=c_8_47_f&fid=32584&url=http%3A%2F%2Fwww.medicalnewstoday.com%2Fmedicalnews.php%3Fnewsid%3D38577%26nfid%3Dcrss UroToday.com - Alpha-blockade continues to be the predominant form of medical therapy for symptomatic bladder outlet obstruction due to BPH. Three alpha 1-adrenoreceptor subtypes have been identified in pharmacological studies, namely alpha-1A, alpha-1B and alpha-1D. Tamsulosin is the first selective alpha-1A adrenoreceptor antagonist in contrast to the non-selective blockers alfuzosin, terazosin and doxazosin. [click link for full article] (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today) Erectile Dysfunction / Premature Ejaculation News From Medical News Today news http://www.medworm.com/rss/comments.php?id=12561 Wed, 01 Mar 2006 11:00:00 +0100 12561 http://www.medworm.com/index.php?rid=4900&cid=c_8_30_f&fid=32303&url=http%3A%2F%2Fdx.doi.org%2F10.1038%2Fsj.eye.6702291 (Source: Eye) Eye journals http://www.medworm.com/rss/comments.php?id=4900 Fri, 24 Feb 2006 07:00:00 +0100 4900 http://www.medworm.com/index.php?rid=21619&cid=c_8_47_f&fid=32593&url=http%3A%2F%2Fdx.doi.org%2F10.1038%2Fsj.pcan.4500849 (Source: Prostate Cancer and Prostatic Diseases)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div> Prostate Cancer and Prostatic Diseases journals http://www.medworm.com/rss/comments.php?id=21619 Tue, 22 Nov 2005 07:00:00 +0100 21619 http://www.medworm.com/index.php?rid=393892&cid=c_8_18_f&fid=34436&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D15555475%26dopt%3DAbstract CONCLUSIONS: In the absence of direct head-to-head comparative trials, the role of alfuzosin ER in the management of symptomatic BPH relative to that of other AARAs is unclear. Because the effect size (drug response minus placebo response) of alfuzosin ER is comparable to that of other AARAs, marked differences in efficacy are unlikely. Extrapolating from direct comparative trials between these agents and alfuzosin IR/SR, alfuzosin ER would be expected to have better cardiovascular tolerability (eg, in terms of dizziness and orthostasis) than prazosin, terazosin, or doxazosin, and to have similar tolerability to tamsulosin. However, the existing data do not suggest that alfuzosin ER is likely to represent a significant advance over tamsulosin. PMID: 15555475 [PubMed - indexed for MEDLI... The American Journal of Geriatric Pharmacotherapy journals http://www.medworm.com/rss/comments.php?id=393892 Mon, 01 Mar 2004 07:00:00 +0100 393892